Clinical Trial of TQB3002 in Patients With Advanced Cancers

Clinical trial NCT06662760 · RECRUITING

Trial details

NCT number: NCT06662760
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2024-12-09
Primary completion: 2025-11-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.